The Nonalcoholic Fatty Liver Disease Fibrosis Score Is Related to Epicardial Fat Thickness and Complexity of Coronary Artery Disease

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a hepatic manifestation of the metabolic syndrome and is associated with cardiovascular disease (CVD). The NAFLD Fibrosis Score (NFS) is an index used for the detection of liver fibrosis. We investigated the relationship between NFS and complexity of coronary artery disease (CAD). In this cross-sectional study, 109 patients with CAD and 50 patients without CAD were enrolled. Demographic data, laboratory parameters, epicardial fat thickness (EFT), NFS, and Synergy between percutaneous coronary intervention with Taxus and cardiac surgery (SYNTAX) score were recorded. Waist circumference, fasting glucose, low-density lipoprotein cholesterol (LDL-C), EFT, and NFS were significantly higher in the CAD group (P < .05). High-density lipoprotein cholesterol (HDL-C) and ejection fraction were significantly lower in the CAD group (P < .05). The SYNTAX score was positively correlated with fasting glucose, LDL-C, EFT, and NFS and negatively correlated with HDL-C (P < .05). The NFS was positively correlated with EFT (P = .019). Multivariate linear regression analysis revealed that NFS (P = .012), EFT (P < .001), and LDL-C (P = .001) were independently associated with the SYNTAX score. In conclusion, NFS, as a marker of NAFLD, could identify patients at higher risk of CVD.

Keywords

coronary artery disease epicardial fat thickness nonalcoholic fatty liver disease fibrosis score

Get full access to this article

View all access options for this article.

References

Rinella

. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313(22):2263–73.

Vernon

Baranova

Younossi

. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274–85.

Xiao

Zhu

Xiao

Yan

Yang

. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis. Hepatology. 2017;66(5):1486–501.

Luo

Zhao

. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease. Eur J Gastroenterol Hepatol. 2015;27(3):193–9.

Kapuria

Takyar

Etzion

Surana

O’Keefe

Koh

. Association of hepatic steatosis with subclinical atherosclerosis: systematic review and meta-analysis. Hepatol Commun. 2018;2(8):873–83.

Choi

Kim

et al. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. Am J Gastroenterol. 2009;104(8):1953–60.

Ghouri

Preiss

Sattar

. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology. 2010;52(3):1156–61.

Angulo

Hui

Marchesini

et al. The NAFLD Fibrosis Score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846–54.

Balta

Demirkol

Kurt

Sarlak

Akhan

. Epicardial adipose tissue measurement: inexpensive, easy accessible and rapid practical method. Anatolian J Cardiol. 2013;13(6):611.

10.

Katsiki

Mikhailidis

Wierzbicki

. Epicardial fat and vascular risk: a narrative review. Curr Opin Cardiol. 2013;28(4):458–63.

11.

Iacobellis

Malavazos

Corsi

. Epicardial fat: from the biomolecular aspects to the clinical practice. Int J Biochem Cell Biol. 2011;43(12):1651–4.

12.

Iacobellis

Ribaudo

Assael

et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab. 2003;88(11):5163–8.

13.

Sianos

Morel

Kappetein

et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1(2):219–27.

14.

Chalasani

Younossi

Lavine

et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol. 2012;107(6):811–26.

15.

Francque

. The role of non-alcoholic fatty liver disease in cardiovascular disease. Eur Cardiol. 2014;9(1):10–15.

16.

Targher

Day

Bonora

. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010;363(14):1341–50.

17.

Assy

Djibre

Farah

Grosovski

Marmor

. Presence of coronary plaques in patients with nonalcoholic fatty liver disease. Radiology. 2010;254(2):393–400.

18.

Akabame

Hamaguchi

Tomiyasu

et al. Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT). Circ J. 2008;72(4):618–25.

19.

Agac

Korkmaz

Cavusoglu

et al. Association between nonalcoholic fatty liver disease and coronary artery disease complexity in patients with acute coronary syndrome: a pilot study. Angiology. 2013;64(8):604–8.

20.

Gruzdeva

Borodkina

Uchasova

Dyleva

Barbarash

. Localization of fat depots and cardiovascular risk. Lipids Health Dis. 2018;17(1):218.

21.

Federico

Dallio

Masarone

Persico

Loguercio

. The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: role of endothelial dysfunction. Eur Rev Med Pharmacol Sci. 2016;20(22):4731–41.

22.

Wang

Lau

. Cardiovascular adiponectin resistance: The critical role of adiponectin receptor modification. Trends Endocrinol Metab. 2017;28(7):519–530.

23.

Simon

Corey

Cannon

et al. The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification, and a strategy for secondary prevention with ezetimibe. Int J Cardiol. 2018;270:245–252.

24.

Gastaldelli

Basta

. Ectopic fat and cardiovascular disease: what is the link? Nutr Metab Cardiovasc Dis. 2010;20(7):481–90.

25.

Wang

Liu

et al. Correlation of echocardiographic epicardial fat thickness with severity of coronary artery disease in patients with acute myocardial infarction. Echocardiography. 2014;31(10):1177–81.

26.

Psychari

Rekleiti

Papaioannou

et al. Epicardial fat in nonalcoholic fatty liver disease: properties and relationships with metabolic factors, cardiac structure, and cardiac function. Angiology. 2016;67(1):41–8.

27.

Iacobellis

Barbarini

Letizia

Barbaro

. Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects. Obesity (Silver Spring). 2014;22(2):332–6.

28.

Katsiki

Mikhailidis

. Abnormal peri-organ or intra-organ fat deposition and vascular risk. Angiology. 2018;69(10):841–842.

29.

Cheng

Hong

Huang

Wan

. How to interpret epicardial adipose tissue as a cause of coronary artery disease: a meta-analysis. Coron Artery Dis. 2012;23(4):227–33.